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The observed changes in the expression levels of the studied
genes indicate their potential role in tumor progression and a
possible impact on their expression of the mutant product of
the BRAF gene. Integrins and their ligands, OPN and TSP1, could
be considered potential markers in determining the prognosis
and treatment of PTC.
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Preoperative differential diagnosis of benign thyroid nodules
and thyroid cancer is an important issue of endocrinology. Preop-
erative identification of a tumor type allows a surgeon to deter-
mine an adequate surgical treatment and reduce complications.
The cytological analysis of samples obtained by the fine-needle
aspiration biopsy is limited in sensitivity and specificity and the
core biopsy is not safe to be used in patients with thyroid nodes
smaller than 2 cm. The most promising area in the preoperative
diagnosis of malignant tumors is molecular biomarkers, which
can be used to determine the surgical treatment and indications
for the target therapy. BRAF V600E is the most frequent genetic
alteration in thyroid cancer. It activates the MAP-kinase pathway
which causes changes in expression levels of extracellular matrix
proteins and some of their receptors. Changes in the expression
of integrin receptors and their ligands, such as osteopontin and
thrombospondin-1, contribute to tumor cell proliferation and
migration. The C-Jun pathway is also very important in pathogen-
esis of thyroid cancer. Changes in its activity can affect the
expression of GSTP enzyme which participates in hormone
metabolism. Altered MiRNA expression has been observed in a
variety of cancer states allowing their potential use as cancer
biomarkers.
The aim of this study was to evaluate integrins, angiogenic
factors, GSTP and MiRNAs as potential biomarkers for the diagno-
sis and prognosis of thyroid cancer.
112 samples of papillary thyroid cancer (PTC) and 120 samples
of benign nodular neoplasms were analyzed. The expression
levels of the studied genes were determined by RT-PCR. The
results were confirmed by immunohistochemical analysis. The
BRAF V600E mutation was determined by allele-specific real-
time PCR. The results showed that GSTP can be used for clinical
settings as a cancer-specific marker for thyroid neoplasms with
83–88% sensitivity, 70–80% specificity and 76–84% diagnostic
accuracy. Higher expression levels of integrins a2, a5, av, a9, b1,
b3 and IL-8, angiogenin, and VEGF were observed in malignant
tumors in comparison with the normal thyroid tissue (p < 0.05).
The BRAF V600E mutation was detected in 70% of all PTC cases.
In the BRAF V600E positive PTC samples the levels of ITGA3 and
ITGAV expression were higher than in the BRAF V600E negative
ones (p < 0.05). The expression of miRNA 21, 221, 222, 155 was
significantly increased in the cancer samples compared to the
benign neoplasms. Thus, the studied molecular markers could
be used for preoperative diagnosis of thyroid neoplasms and the
treatment approach.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.093
A60
The role of metabolic acidosis of peritumoral zone of tumor in
enhanced efficiency of antitumor cytostatics
A. Shihlyarova*, E. Sheiko, T. Kurkina, L. Vladimirova,
N. Abramova, G. Zhukova. Rostov Research Institute of Oncology,
Rostov, Russian Federation
⇑
Corresponding author.
Background: Metabolic acidosis is a feature of many extreme
physiological and pathological conditions; it is characterized by
mitochondria dysfunction, increased membrane permeability
and changes in the conformation of the protein molecules in vio-
lation of their enzymatic properties. In acidosis, intracellular pH
shifts to the acidic side, which gives antitumor effect to the cyto-
static agent the tumor was resistant to. It is known that the per-
itumoral zone is a buffer between the tumor and healthy tissue,
so abnormalities in the tumor microenvironment changing con-
ditions in peritumoral area will likely affect the tumor status
and its response to antitumor therapy. The degree of tissue meta-
bolic acidosis in affected area can be increased by blocking the
activity of mitochondria and their contribution to the energy sup-
ply of the cells and using pharmacological agents that cause sep-
aration of processes of cellular respiration and oxidative
phosphorylation. Thus, the conditions of energy blockade can
be created in the perifocal area of the tumor. The aim was to
study the possibility of increasing the influence of antitumor
cytostatic by modeling damages of the energy forming processes
in the peritumoral area of the tumor through the creation of
metabolic acidosis.
Material and methods: Experimental work fragment was car-
ried out in 60 rats with sarcoma 45 (S45) transplanted under the
back skin. Cyclophosphamide (C) was administered intraperi-
toneally twice at a dose of 5 mg/kg. On the tumor peritumoral
area perimeter (in 4 points) 0.25 ml of a 1% solution of ATP or
1% solution of diphenhydramine (D) were administered. Clinical
studies were performed on 60 patients diagnosedwith breast can-
cer. These patients underwent two cycles of CMFA chemotherapy:
C 800 mg/m2, methotrexate 30 mg/m2, fluorouracil 2000 mg/m2,
doxorubicin 80 mg/m[b]; on a background of peritumoral injec-
tion of 0.5 ml of a 1% solution of ATP or 1% solution of D.
Results: Modelling of metabolic acidosis in peritumoral area
was shown to result in dissociation of respiration processes and
oxidative phosphorylation of cells (suppression of SDH activity
by ATP by 62% and D by 57.9% and an increase in activity of aGFDG
by ATP and D by 154.7%) the ratio of SDH and aGFDG less than 1.
Morphologic study of S45 showed the development of wide
connective border in the subcapsular zone with the inclusion of
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red blood cells, lymphocytes, fibroblasts, histiocytes. The signs of
tumor cell death by activation of apoptosis were observed: shrink-
age and reduction in cell volume, chromatin hyper condensation,
fragmentation of organelles and nucleus, a large amount of
coarse bundles of microfilaments, the presence of apoptotic cells.
Tumor tissue was infiltrated predominantly with CD3 and CD161a
cells, CD45a indicators decreased by 3–4.5 times.
The analysis of antitumor effect in breast cancer patients
depending on factors of energy processes inhibition revealed that
complete tumor regression only in combination with ATP
occurred in 14.2%, and D-in 18.8%, partial regression using ATP
was 71–5%, D – 62.5%. Tumor progression was not observed.
Conclusion: Modulating abnormalities in energy metabolism
due to metabolic acidosis of tumor microenvironment on the
background of systemic chemotherapy, one can achieve activa-
tion of additional pathogenetic mechanisms of inhibition of
tumor growth and tumor cell death. It is necessary to emphasize
the importance of the further search for factors of pathogenetic
mechanisms and therapy of the influence on the tumor, including
the modulation of acidosis of peritumoraly area that opens up
new perspectives in solving this problem.
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Non-small cell lung cancer (NSCLC) is characterized by multi-
ple genetic alterations such as loss of heterozygosity (LOH),
microsatellite instability (MSI), promoter hypermethylation and
changes of miRNA expression. According to a field cancerization
(FC) phenomenon the adjacent histologically normal tissue plays
a role in tumor progression by triggering the transformation
process.
The aim of the study was the analysis of genetic alterations in
tumor and adjacent tissue to determine the FC size and to reveal
associations with clinico-morphological features of patients.
The study group included 135 patients with NSCLC. From each
patient 4 FFPE samples were analyzed: tumor, adjacent normal
lung tissue at 2, 5, 10 cm. LOH/MSI analysis was evaluated by
PCR using 7 microsatellite loci. Promoter hypermethylation in
genes RASSF1A FHIT, DAPK1, CDH1, CD44, TIMP3, MGMT was
investigated by methyl-sensitive PCR. The expression levels of
miRNAs let-7a, miR-155, miR-205 were measured by real-time
PCR.
Our results demonstrated that LOH/MSI occurs only in tumor
while promoter hypermethylation occurs also in adjacent tissue
at 2, 5 cm, but not at 10 cm. The downregulation of let-7a,
miR-155 in adjacent tissue is lower than in tumor. The levels of
investigated miRNAs in adjacent tissue vary depending on tumor
differentiation – in patients with differentiated tumors it is higher
than in the group with poorly differentiated tumors.
We postulate that FC size in NSCLC is at least 5 cm from tumor
and includes only epigenetic but not structural (LOH/MSI)
alterations. The evaluation of epigenetic changes in adjacent
tissue (e.g., surgical margins) can potentially be used for
postsurgical prognosis.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.095
A139
Prevalence and primary prevention of human papillomavirus infec-
tion in Tomsk city and Tomsk region
O. Shpileva. Tomsk Cancer Research Institute, Tomsk, Russian
Federation
Cervical cancer is one of the most common female malignan-
cies with incidence of 19.7 per 100,000 population in Russia in
2011 (Davydov, Aksel et al., 2011). Over 6000 women in Russia
die of cervical cancer annually.
The cervical cancer incidence shows a tendency towards
increasing rates among young women (Chissov, 2009). Tomsk
region has been found to be the territory of increased cancer risk
for cervical cancer. The age-standardized incidence rate is 1.87
times higher in Tomsk region than in Russia, being 20.40/0000
(Pisareva, Odintsova et al., 2012). The highest incidence of cervical
cancer is observed in women aged 15–39 years (Churuksaeva,
Kolomiets, Shpileva, 2012). The causal role of human papillo-
mavirus infections in cervical cancer has been documented
beyond reasonable doubt. Prevention of exposure to high risk
HPV types by vaccination may prove to be the most efficient
and logistically feasible preventive intervention for cervical
cancer.
Epidemiological studies conducted at the Tomsk Cancer
Research Institute have shown that the median age of patients
with cervical intraepithelial neoplasia and cervical cancer is
39.9 ± 8.5, and 89.5% of women are HPV-positive. Prevalence of
high-grade squamous intraepithelial lesion (H-SIL) peaks
between ages 25 years and 30 years.
The predominant HPV type in screened women of Tomsk
region as well as worldwide is HPV-16, reaching peak incidence
in women aged 36–40 years (74%). In the older age group (from
51 to 60 years), HPV-18 is associated with 25% of cervical cancer
cases. High prevalence of HPV-31 has been found in women under
the age of 45 years with an incidence peak (17%) in the age group
620 years.
The geographical widespread data on HPV type-distribution
are essential for estimating the impact of vaccines on cervical
cancer and cervical screening programs. Immunization against
HPV for young women aged between 9 and 26 years, with a pre-
dominant age cohort 11–13 years, was introduced in Tomsk
region in 2010. The aim of the HPV immunization program is to
protect females before they reach an age when the risk of HPV
infection increases. A total of 627 girls were vaccinated, and
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